FGF21 and metabolic disease: PPARs and PGC-1α (peroxisome proliferator-activated receptor γ coactivator 1-α) modulate FGF21 function, and a previous study showed that PPARα agonists ameliorated metabolic disorders in obese mice through modulation of FGF21 expression [119].